Case Reports
Vol. 71 No. 1 (2019)
https://doi.org/10.4081/reumatismo.2019.1041
Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 9 July 2017
Published: 1 April 2019
Published: 1 April 2019
1896
Views
1142
Downloads
Acquired haemophilia A (AHA) is a rare bleeding disorder due to autoantibodies directed against coagulation factor VIII. The treatment is based on recombinant activated factor VII and activated prothrombin complex concentrate. However, mainly in older patients, severe thrombotic complications have been reported. Here we report the different therapeutic approaches in 4 cases of elderly patients with AHA and co-morbidities.
Downloads
Download data is not yet available.
How to Cite
1.
Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases. Reumatismo [Internet]. 2019 Apr. 1 [cited 2026 Aug. 22];71(1):37-41. Available from: https://www.reumatismo.org/reuma/article/view/1041
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
